Research ArticleArticle
Open Access
An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population
Philip C. Robinson, William J. Taylor and Nicola Dalbeth
The Journal of Rheumatology August 2015, jrheum.150310; DOI: https://doi.org/10.3899/jrheum.150310
Philip C. Robinson
From the Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, Brisbane, Queensland; Department of Rheumatology, Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia; Department of Medicine, Wellington School of Medicine, University of Otago, Wellington; Bone and Joint Research Group, University of Auckland, Auckland, New Zealand. This study was an investigator-initiated project funded by AstraZeneca Australia. N. Dalbeth has received consulting fees, speaker fees, or grants from AstraZeneca. W.J. Taylor has received consulting fees or educational grants from AstraZeneca. P.C. Robinson has received consulting fees and research funding from AstraZeneca. P.C. Robinson, MBChB, PhD, FRACP, Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, and Department of Rheumatology, Royal Brisbane and Women’s Hospital; W.J. Taylor, MBChB, PhD, FRACP, Department of Medicine, Wellington School of Medicine, University of Otago; N. Dalbeth, MBChB, MD, FRACP, Bone and Joint Research Group, University of Auckland. Address correspondence to P.C. Robinson, Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, Brisbane, Australia. E-mail: philip.robinson@uq.edu.au Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication May 22, 2015.
William J. Taylor
From the Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, Brisbane, Queensland; Department of Rheumatology, Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia; Department of Medicine, Wellington School of Medicine, University of Otago, Wellington; Bone and Joint Research Group, University of Auckland, Auckland, New Zealand. This study was an investigator-initiated project funded by AstraZeneca Australia. N. Dalbeth has received consulting fees, speaker fees, or grants from AstraZeneca. W.J. Taylor has received consulting fees or educational grants from AstraZeneca. P.C. Robinson has received consulting fees and research funding from AstraZeneca. P.C. Robinson, MBChB, PhD, FRACP, Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, and Department of Rheumatology, Royal Brisbane and Women’s Hospital; W.J. Taylor, MBChB, PhD, FRACP, Department of Medicine, Wellington School of Medicine, University of Otago; N. Dalbeth, MBChB, MD, FRACP, Bone and Joint Research Group, University of Auckland. Address correspondence to P.C. Robinson, Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, Brisbane, Australia. E-mail: philip.robinson@uq.edu.au Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication May 22, 2015.
Nicola Dalbeth
From the Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, Brisbane, Queensland; Department of Rheumatology, Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia; Department of Medicine, Wellington School of Medicine, University of Otago, Wellington; Bone and Joint Research Group, University of Auckland, Auckland, New Zealand. This study was an investigator-initiated project funded by AstraZeneca Australia. N. Dalbeth has received consulting fees, speaker fees, or grants from AstraZeneca. W.J. Taylor has received consulting fees or educational grants from AstraZeneca. P.C. Robinson has received consulting fees and research funding from AstraZeneca. P.C. Robinson, MBChB, PhD, FRACP, Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, and Department of Rheumatology, Royal Brisbane and Women’s Hospital; W.J. Taylor, MBChB, PhD, FRACP, Department of Medicine, Wellington School of Medicine, University of Otago; N. Dalbeth, MBChB, MD, FRACP, Bone and Joint Research Group, University of Auckland. Address correspondence to P.C. Robinson, Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, Brisbane, Australia. E-mail: philip.robinson@uq.edu.au Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication May 22, 2015.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population
Philip C. Robinson, William J. Taylor, Nicola Dalbeth
The Journal of Rheumatology Aug 2015, jrheum.150310; DOI: 10.3899/jrheum.150310